Measuring in vitro biotransformation rates of super hydrophobic chemicals in rat liver S9 fractions using thin-film sorbent-phase dosing

Environmental Science and Technology

Volumn 46, Issue 1, 2012, Pages 410-418

  Lee, Yung Shan ^a   Otton, S Victoria ^a   Campbell, David A ^a   Moore, Margo M ^a   Kennedy, Chris J ^a   Gobas, Frank A P C ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATRIXES; COMMERCIAL CHEMICALS; DOSING SYSTEMS; ENVIRONMENTAL BEHAVIOR; ETHYLENE VINYL ACETATES; HYDROPHOBIC CHEMICALS; IN-VITRO; PROTEIN CONCENTRATIONS; PROTEIN CONTENTS; RAT LIVERS; SOLVENT FREE; SUBSTRATE CONCENTRATIONS; SUPERHYDROPHOBIC;

BIOCONVERSION; CHEMICAL ANALYSIS; ETHYLENE; HYDROPHOBICITY; PROTEINS; RATS; SOLVENTS; SORBENTS; SORPTION;

INDICATORS (CHEMICAL);

CHEMICAL COMPOUND; ETHYLENE VINYL ACETATE COPOLYMER; PROTEIN; SOLVENT; SORBENT;

ACETATE; BIOACCUMULATION; BIOTRANSFORMATION; CONCENTRATION (COMPOSITION); DISSOLUTION; HYDROPHOBICITY; MALE; PROTEIN; RODENT; SORPTION; SUBSTRATE;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; BIOTRANSFORMATION; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DISSOLUTION; EXTRACTION; FILM; FRACTIONATION; HYDROPHOBICITY; IN VITRO STUDY; LIVER HOMOGENATE; MATERIAL COATING; NONHUMAN; PHASE TRANSITION; PROTEIN CONTENT; RAT; THIN FILM SORBENT PHASE; WASTE WATER;

ADSORPTION; ANIMALS; BIOTRANSFORMATION; ENVIRONMENTAL MONITORING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; LIVER; MALE; MODELS, BIOLOGICAL; ORGANIC CHEMICALS; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; SUBCELLULAR FRACTIONS; TIME FACTORS;

MAMMALIA; RATTUS;

EID: 84855313371     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es203338h     Document Type: Article

References (49)

1. Arnot, J. A.; Gobas, F. A. P. C. A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms Environ. Rev. 2006, 14, 257-297
2. Robinson, P.; MacDonald, D.; Davidson, N.; Okonski, A.; Sene, A. Use of quantitative structure activity relationships (QSARs) in the categorization of discrete organic substances on Canada's Domestic Substances List (DSL) Environ. Inf. Arch 2004, 2, 122-130
3. Weisbrod, A. V.; Sahi, J.; Segner, H.; James, M. O.; Nichols, J.; Schultz, I.; Erhardt, S.; Cowan-Ellsberry, C.; Bonnell, M.; Hoeger, B. The state of in-vitro science for use in bioaccumulation assessments for fish Environ. Toxicol. Chem. 2009, 28, 86-96
4. Kelly, B. C.; Ikonomou, M. G.; Blair, J. D.; Morin, A. E.; Gobas, F. A. P. C. Food web-specific biomagnification of persistent organic pollutants Science 2007, 317, 236-239
5. Nichols, J. W.; Bonnell, M.; Dimitrov, S. D.; Escher, B. I.; Han, X.; Kramer, N. I. Bioaccumulation assessment using predictive approaches Integr. Environ. Assess. Manage. 2009, 5, 577-597
6. Nichols, J. W.; Schultz, I. R.; Fitzsimmons, P. N. In-vitro-in-vivo extrapolation of quantitative hepatic biotransformation data for fish-I. A review of methods, and strategies for incorporating intrinsic clearance estimates into chemical kinetic models Aquat. Toxicol. 2006, 78, 74-90
7. Han, X.; Nabb, D. L.; Mingoia, R. T.; Yang, C. H. Determination of xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykis s) and rat and its application in bioaccumulation assessment Environ. Sci. Technol. 2007, 41, 3269-3276
8. Dyer, S. D.; Bernhard, M. J.; Cowan-Ellsberry, C.; Perdu-Durand, E.; Demmerle, S.; Cravedi, J. P. In vitro biotransformation of surfactants in fish. Part I: Linear alkylbenzene sulfonate (C12-LAS) and alcohol ethoxylate (C13EO8) Chemosphere. 2008, 72, 850-862
9. Cowan-Ellsberry, C. E.; Dyer, S. D.; Erhardt, S.; Bernhard, M. J.; Roe, A. L.; Dowty, M. E.; Weisbrod, A. V. Approach for extrapolating in-vitro metabolism data to refine bioconcentration factor estimates Chemosphere 2008, 70, 1804-1817
10. Han, X.; Nabb, D. L.; Yang, C. H.; Snajdr, S. I.; Mingoia, R. T. Liver microsomes and S9 from rainbow trout (Oncorhynchus mykiss): Comparison of basal-level enzyme activities with rat and determination of xenobiotic intrinsic clearance in support of bioaccumulation assessment Environ. Toxicol. Chem. 2009, 28, 481-488
11. Escher, B. I.; Cowan-Ellsberry, C. E.; Dyer, S.; Embry, M. R.; Erhardt, S.; Halder, M.; Kwon, J. H.; Johanning, K.; Oosterwijk, M. T. T.; Rutishauser, S.; Segner, H.; Nichols, J. Protein and lipid binding parameters in rainbow trout (Oncorhynchus mykiss) blood and liver fractions to extrapolate from an in vitro metabolic degradation assay to in vivo bioaccumulation potential of hydrophobic organic chemicals Chem. Res. Toxicol. 2011, 24, 1134-1143
12. Nichols, J. W.; Hoffman, A. D.; Fitzsimmons, P. N. Optimization of an isolated perfused rainbow trout liver model: Clearance studies with 7-ethoxycoumarin Aquat. Toxicol. 2009, 95, 182-194
13. Rane, A.; Wilkinson, G. R.; Shand, D. G. Prediction of hepatic extraction ratio from in-vitro measurement of intrinsic clearance J.Pharmacol. Exp. Ther. 1977, 200, 420-424
14. Houston, J. B. Utility of in-vitro drug metabolism data in predicting in-vivo metabolic clearance Biochem. Pharmacol. 1994, 47, 1469-1479
15. Obach, R. S. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in-vitro half-life approach and nonspecific binding to microsomes Drug Metab. Dispos. 1999, 27, 1350-1359
16. Jones, H. M.; Houston, J. B. Substrate depletion approach for determining in-vitro metabolic clearance: Time dependencies in hepatocyte and microsomal incubations Drug Metab. Dispos. 2004, 32, 973-982
17. Mohutsky, M. A.; Chien, J. Y.; Ring, B. J.; Wrighton, S. A. Predictions of the in-vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations Pharm. Res. 2006, 23, 654-662
18. Hansen, A. R.; Fouts, J. R. Some problems in Michaelis-Menten kinetic analysis of benzpyrene hydroxylase in hepatic microsomes from polycyclic hydrocarbon-pretreated animals Chem. Biol. Interact. 1972, 5, 167-182
19. Robie, K. M.; Cha, Y. N.; Talcott, R. E.; Schenkman, J. B. Kinetic studies of benzpyrene and hydroxypyrene metabolism Chem. Biol. Interact. 1976, 12, 285-297
20. Luisi, P. L.; Baici, A.; Bonner, F. J; Aboderin, A. A. Relationship between fluorescence and conformation of eNAD+ bound to dehydrogenases Biochemistry 1975, 14, 362-368
21. Kwon, J. H.; Wuethrich, T.; Mayer, P.; Escher, B. I. Development of a dynamic delivery method for in-vitro bioassays Chemosphere 2009, 76, 83-90
22. Easterbrook, J.; Lu, C.; Sakai, Y.; Li, A. P. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes Drug Metab. Dispos. 2001, 29, 141-144
23. Hickman, D.; Wang, J. P.; Wang, Y.; Unadkat, J. D. Evaluation of the selectivity of in-vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities Drug Metab. Dispos. 1998, 26, 207-215
24. Li, D.; Han, Y.; Meng, X.; Sun, X.; Yu, Q.; Li, Y.; Wan, L.; Huo, Y.; Guo, C. Effect of regular organic solvents on cytochrome P450-mediated metabolic activities in rat liver microsomes Drug Metab. Dispos. 2010, 38, 1922-1925
25. Mayer, P.; Wernsing, J.; Tolls, J.; de Maagd, P. G. J.; Sijm, D. T. H. M. Establishing and controlling dissolved concentrations of hydrophobic organics by partitioning from a solid phase Environ. Sci. Technol. 1999, 33, 2284-2290
26. Brown, R. S.; Akhtar, P.; Akerman, J.; Hampel, L.; Kozin, I. S.; Villerius, L. A.; Klamer, H. J. C. Partition controlled delivery of hydrophobic substances in toxicity tests using poly(dimethylsiloxane) (PDMS) films Environ. Sci. Technol. 2001, 35, 4097-4102
27. Kiparissis, Y.; Akhtar, P.; Hodson, P. V.; Brown, R. S. Partition-controlled delivery of toxicants: A novel in-vivo approach for embryo toxicity testing Environ. Sci. Technol. 2003, 37, 2262-2266
28. Mayer, P.; Holmstrup, M. Passive dosing of soil invertebrates with polycyclic aromatic hydrocarbons: Limited chemical activity explains toxicity cutoff Environ. Sci. Technol. 2008, 42, 7516-7521
29. Smith, K. E. C.; Oostingh, G. J.; Mayer, P. Passive dosing for producing defined and constant exposure of hydrophobic organic compounds during in-vitro toxicity tests Chem. Res. Toxicol. 2010, 23, 55-65
30. Kramer, N. I.; Busser, F. J. M.; Oosterwijk, M. T. T.; Schirmer, K.; Escher, B. I.; Hermens, J. L. M. Development of a partition-controlled dosing system for cell assays Chem. Res. Toxicol. 2010, 23, 1806-1814
31. Austin, R. P.; Barton, P.; Cockroft, S. L.; Wenlock, M. C.; Riley, R. J. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties Drug Metab. Dispos. 2002, 30, 1497-1503
32. Riley, R. J.; McGinnity, D. F.; Austin, R. P. A unified model for predicting human hepatic, metabolic clearance from in-vitro intrinsic clearance data in hepatocytes and microsomes Drug Metab. Dispos. 2005, 33, 1304-1311
33. McLure, J. A.; Miners, J. O.; Birkett, D. J. Nonspecific binding of drugs to human liver microsomes Br. J. Clin. Pharmacol. 2000, 49, 453-461
34. Gertz, M.; Kilford, P. J.; Houston, J. B.; Galetin, A. Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations Drug Metab. Dispos. 2008, 36, 535-542
35. Golding, C. J.; Gobas, F. A. P. C; Birch, G. E. A fugacity approach for assessing the bioaccumulation of hydrophobic organic compounds from estuarine sediment Environ. Toxicol. Chem. 2008, 27, 1047-1054
36. Meloche, L. M.; deBruyn, A. M. H.; Otton, S. V.; Ikonomou, M. G.; Gobas, F. A. P. C Assessing exposure of sediment biota to organic contaminants by thin-film solid phase extraction Environ. Toxicol. Chem. 2009, 28, 247-253
37. Van, L. M.; Hargreaves, J. A.; Lennard, M. S.; Tucker, G. T.; Rostami-Hodjegan, A. Inactivation of CYP2D6 by methylenedioxymethamphetamine in different recombinant expression systems Eur. J. Pharm. Sci. 2007, 32, 8-16
38. Bates, D. M.; Watts, D. B. Nonlinear Regression Analysis and Its Applications; Wiley: New York, 1988.
39. Cheney, W.; Kimcaid, D. Numerical Mathematics and Computing; Brooks/Cole: Pacific Grove, CA, 1994.
40. Alvares, A. P.; Schilling, G. R.; Kuntzman, R. Differences in kinetics of benzpyrene hydroxylation by hepatic drug-metabolizing enzymes from phenobarbital and 3-methylcholanthrene-treated rats Biochem. Biophys. Res. Commun. 1968, 30, 588-593
41. Zampaglione, N. G.; Mannering, G. J. Properties of benzpyrene hydroxylase in liver, intestinal-mucosa and adrenal of untreated and 3-methylcholanthrene- treated rats J. Pharmacol. Exp. Ther. 1973, 185, 676-685
42. Muhlebach, S.; Wyss, P. A.; Bickel, M. H. The use of 2,4,5,2′, 4′,5′-hexachlorobiphenyl (6-CB) as an unmetabolizable lipophilic model-compound Pharmacol. Toxicol. 1991, 69, 410-415
43. Shen, A. L.; Fahl, W. E.; Wrighton, S. A.; Jefcoate, C. R. Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones Cancer Res. 1979, 39, 4123-4129
44. Fahl, W. E. The kinetics of benzo(a)pyrene anti-7,8-dihydrodiol 9,10-epoxide formation from benzo(a)pyrene and regulatory membrane effects Arch. Biochem. Biophys. 1982, 216, 581-592
45. Keller, G. M.; Turner, C. R.; Jefcoate, C. R. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene- induced rat-liver microsomes Mol. Pharmacol. 1982, 22, 451-458
46. Malinowski, J. J. Two-phase partitioning bioreactors in fermentation technology Biotechnol. Adv. 2001, 19, 525-538
47. Daugulis, A. J. Partitioning bioreactors Curr. Opin. Biotechnol. 1997, 8, 169-174
48. Kalvass, J. C.; Tess, D. A.; Giragossian, C.; Linhares, M. C.; Maurer, T. S. Influence of microsomal concentration on apparent intrinsic clearance: Implications for scaling in vitro data Drug Metab. Dispos. 2001, 29, 1332-1336
49. Gobas, F. A. P. C; Kelly, B. C.; Arnot, J. A. Quantitative structure activity relationships for predicting the bioaccumulation of POPs in terrestrial food-webs QSAR Comb. Sci. 2003, 22, 329-336